$CVSI CV Sciences Generates 31% Adjusted EBITDA Margins as Sales Triple in Q2 to $12.35 Million https://www.newcannabisventures.com/cv-sciences-generates-31-adjusted-ebitda-margins-as-sales-triple-in-q2-to-12-35-million/